Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$96.41 - $126.61 $205,064 - $269,299
2,127 Added 104.68%
4,159 $429,000
Q2 2023

Aug 08, 2023

BUY
$118.5 - $160.53 $60,435 - $81,870
510 Added 33.51%
2,032 $246,000
Q4 2022

Feb 14, 2023

BUY
$118.38 - $210.04 $180,174 - $319,680
1,522 New
1,522 $273,000
Q2 2022

Aug 11, 2022

SELL
$117.13 - $176.59 $138,916 - $209,435
-1,186 Closed
0 $0
Q1 2022

Aug 11, 2022

SELL
$126.46 - $235.05 $245,079 - $455,526
-1,938 Reduced 62.04%
1,186 $204,000
Q4 2021

Aug 11, 2022

BUY
$225.82 - $368.51 $705,461 - $1.15 Million
3,124 New
3,124 $793,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $25.7B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Axxcess Wealth Management, LLC Portfolio

Follow Axxcess Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Axxcess Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Axxcess Wealth Management, LLC with notifications on news.